Scholar's Cultivation System Panel

The major news that cancer has been conquered can be said to be closely related to the life and health of all mankind. Under such circumstances, overseas media naturally conducted relatively large-scale reports after learning about it.

I hope our country can introduce this technology to completely solve the problem of difficult cancer treatment.

Many overseas netizens also discussed it on commonly used platform websites, and the popularity it brought was no less than that in China.

Because of the name of Deepin Technology, and the videos posted by Feng Wanqin and other trial patients, which were also reprinted and uploaded on the website, most people did not doubt the authenticity of this technology. On the contrary, they wished that the technology could be introduced as soon as possible.

After all, according to WHO statistics, there are more than 10 million cancer patients worldwide.

It’s unknown how many people die from cancer every year.

If cancer can be cured, it will be a huge medical progress for the entire human civilization.

But those who have responded the most are definitely the major pharmaceutical companies that have made their fortunes by researching anti-cancer drugs.

It is precisely because cancer cannot be conquered that they need to continuously develop new anti-cancer drugs, which is also the guarantee of their company's profits.

Now that Deepin Technology has developed a new type of chimeric antigen receptor T-cell immunotherapy and announced that it can cure cancer, you can imagine how depressed the market for anti-cancer drugs will be in the future.

This will definitely have a huge impact on them.

Ruihui Biologics is a world-renowned pharmaceutical company that occupies most of the global anti-cancer drug market.

The losses will be greatest at that time.

Therefore, as the CEO, after receiving the news, Abler made the decision without any hesitation and first worked with other pharmaceutical companies to discuss follow-up responses.

Of course, in addition to them, there are also many international organizations who are interested in the research results of Deepin Technology.

…

June 10, 2024, WHO headquarters building in Switzerland's second largest city.

In the office with a flag hanging sideways behind him, Tan Said, as the Director-General, is busy at his desk, dealing with global tuberculosis, malaria and other diseases.

As the world's largest health organization, its mission is to enable people around the world to achieve the highest possible level of health and to promote the prevention and treatment of endemic and endemic diseases.

As the saying goes, the higher the level, the greater the responsibility. It is a difficult and major problem to solve so many diseases in the world.

Just then, a knock on the door outside caught his attention, and he immediately raised his gaze.

"Please come in."

The next second the door opened from the outside, and a middle-aged man with an Asian face walked in.

Tan Said obviously knew the other person, and stood up to say hello before the other person came to the desk.

"My old friend, I haven't seen you for a few days."

Hearing Tan Said's words, Bei Luming, currently a member of the executive committee, immediately responded: "I'm here this time to tell you a very good news." He did not hide the joy on his face when he spoke.

"oh."

"I wonder what kind of good news it is?"

Tan Said was intrigued by Bei Luming's words and asked casually.

In addition to being a member of the executive committee, Bei Luming also studies medicine and is an authoritative technical expert and professor in the health field.

For him to call it good news is definitely extraordinary.

Bei Luming didn't waste any time on this, and then told the other party the good news he knew.

"According to the latest news, Deepin Technology's biological research laboratory has developed a new type of chimeric antigen receptor T cell immunotherapy. They say this technology can cure various types of cancer."

Yes.

The good news mentioned by Bei Luming is that Deepin Technology has developed a new type of chimeric antigen receptor T cell immunotherapy.

After all, it is really great news when it comes to the fight against cancer.

Perhaps because he was busy dealing with the work compiled from various regions, Tan Said did not know about the new Deepin Technology project. After hearing what Bei Luming said, his eyes widened with displeasure. Dare to believe.

"Are you telling the truth?"

"Can it really cure all types of cancer?"

He had natural chimeric antigen receptor T cell immunotherapy and had learned about it before.

But even the most advanced technical team cannot cure cancer patients, let alone all types of cancer.

With this relationship, his first reaction was disbelief.

However, this idea did not linger in his mind for long before he decisively abandoned it.

Very simple.

He knew very well what kind of person Bei Luming was, and he would definitely not talk nonsense about something like this that was related to global human health. Since he raised this matter, it had a higher degree of authenticity.

Although this is really hard to accept.

I just think that if this is the case, then the nearly 20 million cancer patients around the world will benefit from this, and the number of diagnoses will drop significantly by next year.

By then, the pressure on their organization will be much less.

When his thoughts stayed here, he couldn't hold back the excitement in his heart and asked questions as quickly as possible.

Bei Luming was obviously in the same mood as Tan Said, and he didn't dare to delay even a moment after hearing this.

Immediately tell the information you have.

"Given Deepin Technology's reputation in the world, we should not rashly release false information to affect our image. In addition, this matter has also been personally confirmed by the official on the other side."

"From the mouths of many cancer patients who have participated in the trial, we can also see that this new technology does have a strong effect."

"There is also special news. Some people say that Xu Yun, known as the youngest genius in mankind, also participated in the research."

When Bei Luming came to this point, he paused briefly to give Tan Said time to think, and then expressed his views on the matter.

"In fact, regardless of whether this new technology can cure cancer, even if it has a certain effect, it is a major progress."

"You are absolutely right." Tan Said nodded to Bei Luming, as if he had made a decision and said thoughtfully: "Our human battle with cancer has been going on for too long. If we can be sure this time, A remarkable result is a great victory in the history of medicine.”

Almost as soon as he said the last sentence, Tan Saide began to arrange the follow-up itinerary with great solemnity.

"It seems that it is necessary for us to go there and see the real situation of this technology."

"I'll get ready right now." Bei Luming nodded in agreement.

They haven't seen what this new technology actually does anyway.

Even if it is to be promoted globally, it needs to be carefully investigated first. After all, this affects nearly 20 million cancer patients, and there must be no sloppiness.

Otherwise, if we really call on cancer patients in various regions to use this technology, things will be very serious if an emergency occurs.

…

…

While various overseas forces were taking action, Jingzhou City seemed extremely busy.

Although Jingzhou Hospital issued a statement in advance, saying that there is no way to accept more cancer patients, it is still unavoidable that it will be overcrowded.

In this case, the hospital had to deploy personnel from other departments to draw blood from the patients and send it to the biological research laboratory.

Even the First Hospital later reduced the admission of patients with other diseases and diverted them to other hospitals.

It is no exaggeration to say that such a lively and huge scene is probably the first time since the establishment of the hospital.

"Dr. Lin, the blood of these cancer patients has been processed. We will send it to the biological research laboratory immediately." Two ordinary doctors in the department reported the situation to Lin Yi. They were obviously busy and did not stop to rest, but who No complaints.

Lin Yi, who is temporarily in charge of this task, of course understands how hard everyone is working.

After responding, he did not forget to say a few words of relief.

"Pay attention to safety on the road. When the new department in our hospital is ready, we will save a lot of trouble."

"I can see that so many cancer patients can be treated, and no one feels tired." Facing Lin Yi's words, one of the young doctors said with a smile. Judging from the look on his face, it was obviously from the heart.

"We're going over there, Dr. Lin."

He spoke again, and then the two turned and left.

Lin Yi looked at the backs of the two people until the figures completely disappeared from the field of vision, and then looked back at the information on the table.

It has been less than two weeks since the launch of the new chimeric antigen receptor T-cell immunotherapy, and the condition of the first batch of patients who have completed injections has improved significantly after examination.

The number of cancer cells in the body dropped significantly instantly.

This made patients who were still a little scared completely let go of Xinlai.

At the same time, there are more treatment groups, and after proving the powerful therapeutic effect of this technology, it can be said that cancer patients who have not yet received treatment are even more crazy.

Some wealthy patients even spend a lot of money to get priority treatment.

Unfortunately, currently only biological research laboratories are capable of treatment, and in order to ensure efficiency, the entire process is connected to Deepin Technology's artificial intelligence Benben.

It is basically impossible to purchase a quota.

We can only control the condition with conventional treatment while waiting for more hospitals to open new departments.

As Lin Yi said just now, in order to ensure that cancer patients can receive new technology treatments, the first batch of key hospitals will receive support to establish new departments.

This new department has an environment for cell modification and expansion, and will be dedicated to the treatment of cancer patients in the future.

When these departments are officially opened to the outside world, the pressure on Jingzhou will be greatly reduced in an instant.

at the same time.

In the biological research laboratory of Longhu Science and Technology Park, Xu Yun, wearing research clothes, is busy in the operation room.

Although he does not need to personally participate in his capacity, after all, the transformation and expansion of cells have been streamlined, and even a newly arrived doctoral researcher assistant can be responsible for it, but because there are too many cells to be processed every day during this period, , due to the shortage of laboratory personnel, he had to do it himself.

I even have to work overtime every day before going home to spend time with my family.

But there is nothing that can be done. After all, if you work more, you may be able to treat one more cancer patient.

Save a family.

While waiting for the new patient's blood sample to be delivered, Ding Wei took advantage of the opportunity to find Xu Yun.

"I have something to discuss with you, Xu Academy. Dean Li from the Academy of Engineering said he would come to the laboratory today. Also accompanying him are Tan Said, Director-General of the World Health Organization, and Ms. Spurkey, Editor-in-Chief of Nature Magazine."

After hearing what Ding Wei said, Xu Yun couldn't help but raise his eyes to make himself more serious.

Dean Li of the Academy of Engineering naturally knew about it, so there was nothing wrong with coming to the laboratory to check on the situation.

As the world's top scientific magazine, Nature will definitely be very interested in major research topics such as overcoming cancer, and they will want to understand the situation and report it to the outside world.

However, he was quite surprised that it attracted the attention of an international organization so quickly, and that the director-general came in person.

Everyone is equal in the face of cancer. If given the opportunity, he would certainly not mind applying this technology to the world to cure more cancer patients.

Of course, the premise is that overseas regions are willing to accept technology authorization and introduce this technology to them.

Otherwise, those overseas patients may have no choice but to go to Jingzhou for treatment.

The thought stayed here, Xu Yun thought for a while and said: "Then you can take time to accompany them in the afternoon to introduce the situation."

But Ding Wei did not accept this readily. Instead, he shook his head and said: "They are all here for you, Xu Yuan. It doesn't matter if I stand up. Doesn't this make everyone unhappy?" Obviously he had already I have made a specific plan about this matter.

It was true that he was the initiator of the laboratory's chimeric antigen receptor T-cell immunotherapy project, but Xu Yun was the one who upgraded the technology, and he would not take the credit.

Facing Ding Wei's answer, Xu Yun could also understand what the other party was thinking.

Although I didn’t like this kind of occasion very much, I thought about the positive impact that WHO and Nature magazine could bring, so I finally had to agree.

"I understand, I will receive them when the time comes."

"Then I'll be relieved." Ding Wei took Xu Yun's words and responded.

——

It has to be said that Li Houlin and his party were really in a hurry. Shortly after finishing their meal in the afternoon, they arrived at Jingzhou Longhu Science and Technology Park.

Because he had greeted him in advance in the morning, Xu Yun took someone over to greet him after receiving the news.

"Dean Li, you are welcome to guide our work."

Xu Yun stepped forward to shake hands with Li Houlin and said with a smile.

In response, Li Houlin quickly joked: "Just come here today and treat us as students. I can't talk about guidance here as an academician of Xu University."

Obviously he has a clear understanding of himself and does not promote himself because of his status as dean.

After responding, Xu Yun took the initiative to introduce the people he was traveling with this time without waiting for anything more.

"Let me introduce you first."

"This is Mr. Tedros Adhanom Ghebreyesus, Director-General of the World Health Organization, and Professor Bell Ming, a member of the Executive Committee."

"Ms. Spurkey is the current editor-in-chief of Nature magazine. They value your laboratory's research project very much."

As Li Houlin finished his introduction, Xu Yun also extended his arms to shake hands and say hello.

Soon the atmosphere became familiar.

It is worth mentioning that although he had dealt with nature and science magazines before, Ms. Spurkey was obviously the new editor-in-chief.

Have not met before.

At this moment, Tan Saide's attention was entirely on Xu Yun, and he took the opportunity to carefully look at this young man who was called the most talented scientist in mankind. If Xu Yun had not made so many achievements, I am afraid that no one would have done it. Ways to connect with the young people in front of you.

Holding back his excitement for the time being, until everyone officially entered the biological research laboratory, Tan Said noticed the busy researchers around him, and then he couldn't help but ask.

"Academician Xu."

"Can you tell us about your laboratory's latest chimeric antigen receptor T cell immunotherapy project?"

Almost as soon as Tan Said finished speaking, the editor-in-chief of Nature magazine, Ms. Spurkey, who was next to her, also echoed: "This topic has caused huge discussions in the entire medical community. We at Nature magazine are also prepared to continue to pay attention and witness that cancer is conquered. .”

Bei Luming, a technical expert in the health field next to him, did not speak in this situation, but his attention was always on Xu Yun.

Xu Yun understood that they were all here for the latest chimeric antigen receptor T-cell immunotherapy technology in the laboratory, and in this case they would not deliberately show off.

Then he started talking while walking.

"I think everyone here is familiar with chimeric antigen receptor T cell immunotherapy."

“Using this therapy allows for customized treatment plans for patients, modifying cells to eliminate cancer cells.”

"However, this traditional therapy has shortcomings such as long cycle time, corresponding side effects and poor effects on patients. Our laboratory is optimizing and upgrading the technology based on this therapy."

"The resulting new therapy not only has a short cycle of cell modification and expansion, but also has no side effects on patients."

"In addition, in addition to being effective in treating all known cancers, the cost of treatment is only about one-tenth of traditional methods."

The few people who had been relatively calm just now could no longer control their excitement after hearing what Xu Yun said about the technical advantages.

What concept does this represent?

According to what Xu Yun said, if it is promoted globally, it will not only reduce the number of cancer patients to a very low level, but also will not cost too much money.

You must know that in recent years, due to the arrears of membership dues in many regions, the organization's foundation funds are really not sufficient.

If the treatment cost of this new type of therapy is as high as several million, even if it has a good curative effect, it will be very troublesome to promote it in a short period of time.

It may even be caught by those pharmaceutical companies and make a fuss to prevent the promotion of this technology.

Belluming is a technical expert in related fields, and he has also conducted research on chimeric antigen receptor T cell immunity.

So he knows how difficult it is to improve efficiency, avoid side effects, and reduce treatment costs.

It is no exaggeration to say that it may take a long time for the research team to work out just one of them.

Otherwise, this technology will not be without breakthrough progress for a long time.

But in the laboratory of Deepin Technology, the original difficulty seems to have been completely ignored, and the technology can be optimized and upgraded to such an incredible level so easily.

This made him couldn't help but wonder what kind of special magic power this laboratory had.

His thoughts stayed here, and the next second he seemed to think of something. Before Xu Yun could continue, he took advantage of the gap to ask.

"I wonder if there is any detailed data to support what you are saying?"

After hearing this, Xu Yun turned around and looked at the executive committee member with a familiar face. With a smile on his lips, he answered with great confidence: "I think those cancer patients we have successfully cured during this period will be the most powerful ones." Data support.”

What he said is absolutely correct. By this time, the new chimeric antigen receptor T cell immunotherapy no longer requires any data proof.

Those cancer patients who have been cured are the best illustration.

Having said this, Xu Yun continued to introduce it, letting them know the general process of this technology.

Not long after.

When everyone returned to the lounge, it could be said that they were completely convinced that the new chimeric antigen receptor T-cell immunotherapy could conquer cancer.

I just felt deeply shocked inside.

In fact, Tan Said was still a little skeptical before he came, fearing that the joy would be in vain in the end.

But Xu Yun made him truly understand why the other party could be called the most talented young scientist in human history.

Even if all of Xu Yun's previous achievements are ignored, the development of a new chimeric antigen receptor T cell immunotherapy technology alone is enough to be forever remembered in the history of human civilization.

At this time, Tan Saide finally made up his mind, then turned his attention to Xu Yun and said solemnly:

"Academician Xu."

"This new chimeric antigen receptor T cell immunotherapy technology developed by you and your laboratory is really great for all cancer patients around the world."

"This will effectively reduce the number of cancer patients worldwide."

"So on behalf of the WHO, I would like to ask for authorization to use this technology."

Xu Yun originally wanted to use this technology to treat more cancer patients. It can be said that he was very happy that an international organization was willing to help.

So he agreed directly without any hesitation: "Of course there is no problem."

After speaking, he added: "In addition, other companies or hospitals can also come to purchase technology licenses from us." He always smiled when he spoke, making people feel like spring breeze.

"That's really great. When I go back, I will personally call on all regions around the world to take action." Tan Said was very satisfied with Xu Yun's decision and immediately said that he would provide help at that time.

It is also worth mentioning that Ms. Spurkey, the editor-in-chief of Nature magazine, also stated that she would report this topic in the latest journal.

Maybe what they saw and heard today was too exciting for them. They originally wanted to keep them in Jingzhou for dinner, but in the end they all expressed that they wanted to go back as soon as possible to start corresponding work.

Naturally, Xu Yun couldn't stop him, so he had no choice but to invite them to visit Jingzhou when they had time in the future.

However, Li Houlin only allowed the following people to accompany him, and he stayed in Longhu Science and Technology Park for the time being.

When he was the only one left, Li Houlin finally became active and looked at Xu Yun with as much satisfaction as he wanted.

"I knew that with your talent there would be no problem, and now it proves that my judgment was indeed correct."

"You have only been exposed to the fields of medicine and genetic engineering for a short period of time, and you have successfully optimized and upgraded Lao Ding's research projects for many years. This is something that no one else in the hospital would dare to think of."

"How about it, do you want to enter the Engineering Academy?"

At the dinner table, Li Houlin did not hide his purpose at all, and asked openly in front of others.

Ever since Xu Yun was elected as an academician of the Academy of Sciences, he has felt envious every time he saw new project results coming out, forcing the Academy of Sciences, which mainly focused on theory, to overwhelm them.

It was no exaggeration to say that sometimes in his dreams he wished that Xu Yun was from their engineering academy.

This time Xu Yun took the initiative to get involved in medical genetic engineering, which finally gave him hope.

I want to find an opportunity for Xu Yun to be elected as an academician of the Academy of Engineering.

Nowadays, the new chimeric antigen receptor T-cell immunotherapy has shocked the entire medical community around the world. It is unknown how many cancer patients can return to normal lives. This achievement is enough to be elected as an academician of the Academy of Engineering.

Today he specially traveled from the Imperial Capital to accompany Tan Said, Spurkey and others. Another thing he wanted to do was to formally invite Xu Yun.

"Join the Academy of Engineering?"

The topic was suddenly brought to this matter, Xu Yun was not expecting it, and couldn't help but be a little startled.

He had never thought about joining the Academy of Engineering again, and he didn't know how to answer it.

However, this reaction made Li Houlin worried, so he quickly opened his mouth and continued to persuade.

"With these two top research institutes, only over 30 people have been awarded the honor of being academicians of the two institutes since their establishment."

"You are the first one as young as you."

When he said this, he didn't forget to wink at Ding Wei next to him, meaning that you, the old boy, are from the Engineering Academy, so why don't you hurry up and help at this time.

Ding Wei didn't know the meaning in Li Houlin's eyes, so he had to put down his chopsticks temporarily and intervene.

"There are indeed very few academicians who can win the honor of being an academician of the two academies. For example, I was only an academician of the Academy of Engineering until my retirement. To be honest, being an academician of the two academies as young as you, Xu Yuan, is really enviable."

As for Professor Zhou Lihua opposite, she remained silent and said nothing when faced with this situation.

After all, there was nothing that could be done about it. She was the lowest ranked professor in the room, and the others were an old academician, a dean, and the youngest academician of the two academies. She really didn't leave any way for others to survive.

If you think about it carefully, Xu Yun is not resistant to the Academy of Engineering, not to mention that some key projects still rely on the Academy of Engineering.

Besides, becoming an academician of the two academies will make it easier for him to conduct research, so there is really no reason to refuse from any point of view.

With his thoughts stuck here, Xu Yun had no choice but to say: "Then just do what Dean Li said."

"That's right. I'll have to have a good chat with you, Dean Hou, then." After receiving Xu Yun's affirmative answer, Li Houlin was immediately relieved and had a bright smile on his face.

After dinner, Li Houlin temporarily stayed in the arranged hotel and returned to the imperial capital the next day.

And just when Tanside and Spurkey started taking action after returning, Ruihui Biotech finally made a decision.

After discussions with other well-known pharmaceutical companies, they understood that with the launch of the new technology by Deepin Technology, it would be impossible to successfully recover Yafang's anti-cancer drug market.

After all, it is the home of Deepin Technology.

In this case, they can only choose to cut off their strength and strive to retain the overseas anti-cancer drug market.

No matter what method is used.

Anti-cancer drugs account for most of the company's business, and the losses caused by a serious hit are immeasurable, so we have to try regardless of whether we can succeed in the end.

——

"Let's implement the plan passed at the meeting. While we still have an advantage, we must continue to expand our advantage."

In the CEO office of Nuoyue Ruihui Biological Headquarters, Ai Bo Le gave instructions to Paina across from him with a calm face.

After experiencing the deep-tech biological research laboratory, it can be said that nothing can cause him any trouble.

Originally, the new drug was performing well, and it had just been launched, which was a good time for the company to recover its research and development costs and earn profits. However, a new type of chimeric antigen receptor T-cell immunotherapy suddenly appeared, and the key was to crush their anti-cancer drugs in all aspects.

It can be said that if you compete head-on, you can't beat it at all.

no way.

Only special measures can be taken.

"If Deepin Technology launches their technology at this time, I am afraid that it will not only satisfy part of the market. Can our solution alone prevent them from entering the global market?"

Facing her boss's instructions, Paina did not immediately carry out the instructions.

Instead, he expressed his worries.

The so-called plan passed at the meeting is to make everyone believe that the new technology of Deepin Technology is unreliable and does not have the effect as advertised.

Coupled with the side effects that are much higher than those of drugs, it will naturally make people think carefully.

Although this method of throwing dirty water is quite crude, it is practical as long as it is effective.

At that time, they just need to unite to prevent the introduction of this technology.

Then you can guarantee your own market.

What's more, they have no other option.

The one who developed this technology is Deepin Technology.

Faced with Paina's worries, Ai BoLe slowly raised his gaze and sighed before answering.

"You have to understand that our opponent this time is Deep Technology, and this is all we can do right now."

"I know, boss." Paina nodded and replied.

Although she still wanted to say something, seeing the look on her boss's face, she swallowed her words again.

Then he turned and walked outside the office.

Although the last negotiation in the imperial capital failed, I have to say that Paina is still very efficient in what she does.

Almost immediately, on the platforms with the largest number of overseas users, there were many voices questioning Deepin Technology's new chimeric antigen receptor T cell immunotherapy, including many professors and scholars with certain authority in the medical field.

Because the technology of Deepin Technology is so powerful that it makes people feel unreal, and with the increasing number of doubtful comments, even people with some ideas will have self-doubt.

I don’t know whether to give up the idea and still choose traditional treatment options.

But just when the situation was developing towards the pharmaceutical company, Tan Saide suddenly held a press conference and announced that he would cooperate with Deepin Technology to use new chimeric antigen receptor T cell immunotherapy to treat cancer diseases.

At the same time, the press conference highly affirmed the powerful effect of the new chimeric antigen receptor T cell immunity and called on all regions to actively and in-depth friendly cooperation in science and technology.

Let’s work together to eliminate cancer worldwide.

In addition, on the same day, Nature magazine released a new issue. In addition to using the topic of the Deep Technology Bioresearch Laboratory as the cover, it also reported the research process of this technology.

The most important thing is that Xu Yun's important role in this project was announced.

Let everyone know that Xu Yun, known as the most talented scientist in mankind, not only set foot in a new field, but also created another miracle to conquer cancer, which is an important step forward for the development of human medicine.

…